Clinical Trial Update: Cholic Acid for Hepatic Steatosis in Lipodystrophy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating cholic acid for hepatic steatosis in lipodystrophy has completed, with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Steatosis
• Lipodystrophy

Drugs mentioned

• Cholic acid (cholic acid)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Hepatic Steatosis | Phase 2 | Status: COMPLETED | Results posted: 2019-01-15